Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMineral & Financial Investments Regulatory News (MAFL)

Share Price Information for Mineral & Financial Investments (MAFL)

Share Price is delayed by 15 minutes
Get Live Data
44.00    0.00 (0.00%)
Bid:
43.00
Ask:
45.00
Spread: 2.00 (4.651%)
Market Cap: £17.10m
MAFL Live PriceLast checked at - London Stock Exchange

Intraday Mineral & Financial Investments Share Chart

Issue of Equity

10 Apr 2025 07:00

RNS Number : 3940E
Mineral & Financial Invest. Limited
10 April 2025
 

Mineral and Financial Investments Limited

(the "M&FI" or the "Company")

 

Issue of Equity

 

The Company announces that it has received a notice of exercise in respect of share options over 250,000 ordinary shares of 1.0p each in the Company at an exercise price of 13.50 pence.

 

Application has been made for 250,000 new ordinary shares each in the Company ("New Ordinary Shares") to be admitted to trading on AIM. The New Ordinary Shares will rank pari passu with the Company's existing ordinary shares and it is expected that admission will occur at 8.00 a.m. on 15 April 2025.

 

Following admission of the New Ordinary Shares, the Company's issued ordinary share capital will comprise 37,355,871 ordinary shares, none of which are held in treasury. Therefore, the total number of ordinary shares with voting rights in following admission will be 37,355,871.

 

The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

 

FOR MORE INFORMATION:

Jacques Vaillancourt, Mineral & Financial Investments Ltd. +44 780 226 8247

Katy Mitchell, Zeus +44 203 829 5000

Jon Belliss, Novum Securities Limited +44 207 382 8300

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEFLFVRSDIAIIE
Date   Source Headline
28th May 20269:22 amRNSHolding(s) in Company
18th Mar 20267:00 amRNSInterim Results
30th Jan 20263:09 pmRNSConversion Of Vested RSUs into Ordinary Shares
28th Jan 20267:00 amRNSHolding(s) in Company
27th Jan 202611:38 amRNSHolding(s) in Company
20th Jan 20261:06 pmRNSResult of AGM
20th Jan 20267:00 amRNS1st Quarter Results
22nd Dec 20257:00 amRNSAudited Results for Year Ended 30 June 2025
22nd Dec 20257:00 amRNSAudited Results for Year Ended 30 June 2025
7th Oct 20252:35 pmRNSDirector/PDMR Shareholding
20th Aug 20258:45 amRNSGrant of RSU's and Exercise of Options
14th Jul 202511:22 amRNSUpdate on Redcorp's Lagoa Salgada EIA Application
12th Jun 20256:18 pmRNSHolding(s) in Company
6th Jun 20259:39 amRNSDirector/PDMR Shareholding
2nd Jun 20257:00 amRNSUnaudited Quarterly Results
22nd May 20255:28 pmRNSDirector/PDMR Shareholding
7th May 20255:21 pmRNSDirector/PDMR Shareholding
7th May 20254:26 pmRNSDirector/PDMR Shareholding
10th Apr 20257:00 amRNSIssue of Equity
20th Mar 20255:13 pmRNSInvestment in Physical Silver
20th Mar 20257:00 amRNSInterim Results for Six Months Ended 31 Dec 24
7th Mar 202511:45 amRNSHolding(s) in Company
4th Feb 20257:00 amRNSInvestment Update: Ascendant
22nd Jan 202512:20 pmRNSDirector/PDMR Shareholding
16th Jan 20251:24 pmRNSReplacement: Unaudited Quarterly Net Asset Value
16th Jan 20257:00 amRNSUnaudited Quarterly Net Asset Value
18th Dec 20242:52 pmRNSResult of AGM
11th Dec 202411:05 amRNSInvestment Update: Ascendant / Redcorp
25th Nov 20242:37 pmRNSHolding(s) in Company
19th Nov 20245:53 pmRNSAudited Results for Year Ended 30 June 2024
1st Nov 202411:03 amRNSInvestment Update: Ascendant / Redcorp
15th Oct 202411:00 amRNSInvestment Update: Redcorp
30th Sep 202411:00 amRNSInvestment Update: Ascendant / Redcorp
19th Sep 20247:00 amRNSInvestment Update: Ascendant / Redcorp
17th Jul 20247:00 amRNSInvestment Update: Redcorp
15th Jul 20247:00 amRNSChange of Nominated Adviser and Broker
12th Jul 20247:00 amRNSDirector Update
13th Jun 20247:00 amRNSUnaudited Quarterly Net Asset Value
29th Apr 20247:00 amRNSDirector Dealing
10th Apr 20244:22 pmRNSHolding(s) in Company
10th Apr 202411:00 amRNSInvestment Update: Ascendant / Redcorp
27th Mar 20247:00 amRNSInterim Results for Six Months Ended 31 Dec 23
29th Feb 20241:01 pmRNSCorrection - Investment Update: Ascendant /Redcorp
29th Feb 20247:00 amRNSInvestment Update: Ascendant / Redcorp
5th Feb 20247:00 amRNSUnaudited Quarterly Net Asset Value
31st Jan 20246:04 pmRNSResult of AGM
8th Jan 20247:00 amRNSDirector Dealing
3rd Jan 202411:00 amRNSInvestment Update: Ascendant / Redcorp
28th Dec 20232:29 pmRNSNotice of AGM and Posting of Annual Report
20th Dec 20235:25 pmRNSAudited Results for Year Ended 30 June 2023

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.